Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas

Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas

PurposeNon-functioning pituitary adenomas (NFPAs) exhibit high recurrence rates after surgery. However, the determinants of recurrence are inconsistent in the available literature. The present study sought to investigate the association between nuclear phosphorylated EGFR (pEGFR) levels and recurren...

Full description

Bibliographic Details
Main Authors: Ashutosh Rai, Liza Das, Kanchan K. Mukherjee, Sivashanmugam Dhandapani, Manjul Tripathi, Chirag Kamal Ahuja, Bishan Dass Radotra, Pinaki Dutta
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Endocrinology
Subjects:
pEGFR T693
non-functioning pituitary adenomas
recurrence
biomarker
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.708111/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.708111/full

Similar Items